
Pneumococcal
Latest News
Latest Videos

Shorts



CME Content
More News

The novel tool can be used to inform vaccine policy, monitor impact, and essentially strengthen overall surveillance.

A case shows a suspected recurrence of pneumococcal disease that ended with removal of one cochlear implant and replacement of the other.

A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.

Cohort studies found no clear cardiovascular benefit from PPV23 vaccination, leaving its role in cardiovascular prevention unresolved.

Data show that commercially and Medicaid-insured children with chronic or immunocompromising conditions incur 2- to 3-fold higher costs.

A persistence of pneumococcal meningitis among adults transformed the disease into a public health concern pharmacists fight on a population-wide scale.

An analysis found all-cause pneumonia Black, lower-income, and medically at-risk children still face substantially higher rates of hospitalization.

Live attenuated influenza vaccine increased pneumococcal density in vaccinated children, raising odds of pneumococcal infection among household contacts.

New consensus confirms that chronic obstructive pulmonary disease, asthma, bronchiectasis, and lung cancer are indications for pneumococcal vaccination.

Focusing on serotype distribution, resistance trends, and vaccination impact, researchers analyze invasive pneumococcal disease burden.

Giving 15-valent pneumococcal conjugate vaccine alongside acellular DTaP did not compromise antibody responses to either vaccine.

For patients with confirmed invasive pneumococal disease, researchers compare the effects of serotype 4 with additional strains.

Across 3 survey periods spanning 2017 to 2023, researchers assess various institutions’ knowledge of pneumococcal vaccination.

Researchers aimed to better understand the prominence of vaccine failures and breakthrough infections of pediatric pneumoccoal immunization.

Researchers highlight the importance of vaccination for the risk reduction needed across the pediatric population.

A study found antibody deficiencies and monoclonal immunoglobulins in a share of adults hospitalized with invasive pneumococcal disease.

A 4-year cohort study finds pneumococcal vaccine serotypes circulating and increasing among older adults with community-acquired pneumonia.

In part 2, Paul Licciardi, PhD, dives into the evolving need for updated pneumococcal vaccine recommendations and how pharmacists can keep their patients informed.

Among adult patients who have reported a case of invasive pneumococcal disease, researchers address the association of risk factors and recurrent disease.

A new surveillance study shows pneumococcal vaccine shifts cut key antibiotic resistance for invasive pneumococcal disease.

Researchers assess the impact of various pneumococcal conjugate vaccines since the introduction of immunization programming.

Machine learning can uncover immune responses to conserved pneumococcal protein antigens.

The pneumococcal vaccine is approved for protection against 21 serotypes in adults over 18 and children between 2 and 17 at high risk of disease.






































